PROCEPT BioRobotics Corporation

PRCT.MX·Mexico·Healthcare
Compare
378.37+10.57 (+2.87%)today
At close: Nov 3, 10:10 AM CST · May be delayed up to 20 min · MXN

Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close367.80
Open367.80
Day range367.80378.37
52-week range320.001,217.38
Off day high0.00%
Off 52-week high−68.92%
Volume2.50K
Avg. volume (3M)124
Market cap21.67B
EPS (TTM)-34.91
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.84
Shares outstanding57.27M
Short interest—
Earnings dateNov 4, 2026
Analyst target—
Profit margin−32.54%

Against its peers

Compare in full ›
PRCT.MX 2252.HK 7779.T 0853.HK 7777.T HAE
Market cap 21.67B 21.84B 40.75B 11.62B 41.21B 5.80B
P/E (TTM) — — 147.3 — 12.0 61.6
Forward P/E — 70.6 128.7 23.3 -25.2 22.1
Price/book 3.1 45.3 1.0 1.5 5.7 6.9
Dividend yield — — — — — —
1-year change −69.79% −16.55% +6.63% −46.33% +2.13% +137.15%
Today +2.87% 0.00% 0.00% 0.00% −4.17% +5.94%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 20 min.

Latest news

All PRCT.MX news ›
The Manila Times··2 outletsPositive

PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026

SAN JOSE, Calif., Oct. 12, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (the 'Company”) (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today…

More from 1 other outlet
Markets Daily·Positive

Critical Survey: PROCEPT BioRobotics (PRCT) versus Its Peers

Posted by Mitch Edgeman on Oct 31st, 2026 PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) is one of 511 public companies in the “Healthcare Equipment & Supplies” industry, but how does it compare to its rivals? We will compare PROCEPT…

markets.businessinsider.com·Positive

Procept BioRobotics initiated with an Overweight at Barclays

Barclays analyst Christopher Pasquale initiated coverage of Procept BioRobotics (PRCT) with an Overweight rating and $30 price target The firm ... Procept BioRobotics initiated with an Overweight at Barclays Barclays analyst Christopher…

From the 4Search news index, newest first.

In the news

40mentions in 30 days
33with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 40 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance